AAAAAA
Results: 1-25/60
Authors:
MONTGOMERY SA
KASPER S
Citation: Sa. Montgomery et S. Kasper, DEPRESSION - A LONG-TERM ILLNESS AND ITS TREATMENT, International clinical psychopharmacology, 13, 1998, pp. 23-26
Authors:
MONTGOMERY SA
Citation: Sa. Montgomery, EFFICACY AND SAFETY OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITORS INTREATING DEPRESSION IN ELDERLY PATIENTS, International clinical psychopharmacology, 13, 1998, pp. 49-54
Authors:
TERRA JL
MONTGOMERY SA
Citation: Jl. Terra et Sa. Montgomery, FLUVOXAMINE PREVENTS RECURRENCE OF DEPRESSION - RESULTS OF A LONG-TERM, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, International clinical psychopharmacology, 13(2), 1998, pp. 55-62
Authors:
MONTGOMERY SA
REIMITZ PE
ZIVKOV M
Citation: Sa. Montgomery et al., MIRTAZAPINE VERSUS AMITRIPTYLINE IN THE LONG-TERM TREATMENT OF DEPRESSION - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, International clinical psychopharmacology, 13(2), 1998, pp. 63-73
Authors:
MONTGOMERY SA
KASPER S
Citation: Sa. Montgomery et S. Kasper, SIDE-EFFECTS, DROPOUTS FROM TREATMENT AND COST CONSEQUENCES, International clinical psychopharmacology, 13, 1998, pp. 1-5
Authors:
MONTGOMERY SA
SCHATZBERG AF
Citation: Sa. Montgomery et Af. Schatzberg, REBOXETINE - A NEW SELECTIVE ANTIDEPRESSANT FOR THE TREATMENT OF DEPRESSION, The Journal of clinical psychiatry, 59, 1998, pp. 3-3
Authors:
MONTGOMERY SA
Citation: Sa. Montgomery, THE PLACE OF REBOXETINE IN ANTIDEPRESSANT THERAPY, The Journal of clinical psychiatry, 59, 1998, pp. 26-29
Authors:
MONTGOMERY SA
KREMER CME
Citation: Sa. Montgomery et Cme. Kremer, MIRTAZAPINE IN LONG-TERM TREATMENT OF DEPRESSION, Biological psychiatry, 43, 1998, pp. 356-356
Authors:
SKERRITT U
EVANS R
MONTGOMERY SA
Citation: U. Skerritt et al., SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN OLDER PATIENTS - A TOLERABILITY PERSPECTIVE, Drugs & aging, 10(3), 1997, pp. 209-218
Authors:
MONTGOMERY SA
Citation: Sa. Montgomery, THE NEED FOR LONG-TERM TREATMENT OF DEPRESSION, European neuropsychopharmacology, 7, 1997, pp. 309-313
Authors:
MONTGOMERY SA
Citation: Sa. Montgomery, IS THERE A ROLE FOR A PURE NORADRENERGIC DRUG IN THE TREATMENT OF DEPRESSION, European neuropsychopharmacology, 7, 1997, pp. 3-9
Authors:
MONTGOMERY SA
Citation: Sa. Montgomery, REBOXETINE - ADDITIONAL BENEFITS TO THE DEPRESSED PATIENT, J PSYCHOPH, 11(4), 1997, pp. 9-15
Authors:
MONTGOMERY SA
Citation: Sa. Montgomery, SOCIAL PHOBIA - THE NEED FOR TREATMENT, International clinical psychopharmacology, 12, 1997, pp. 3-9
Authors:
VERSIANI M
AMREIN R
MONTGOMERY SA
Citation: M. Versiani et al., SOCIAL PHOBIA - LONG-TERM TREATMENT OUTCOME AND PREDICTION OF RESPONSE - A MOCLOBEMIDE STUDY, International clinical psychopharmacology, 12(5), 1997, pp. 239-254
Authors:
MONTGOMERY SA
Citation: Sa. Montgomery, DIRECT LINK TO PDF - INTRODUCTION, International clinical psychopharmacology, 12, 1997, pp. 1-2
Authors:
MONTGOMERY SA
Citation: Sa. Montgomery, FAST-ONSET ANTIDEPRESSANTS, International clinical psychopharmacology, 12, 1997, pp. 1-5
Authors:
PUECH A
MONTGOMERY SA
PROST JF
SOLLES A
BRILEY M
Citation: A. Puech et al., MILNACIPRAN, A NEW SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR - AN OVERVIEW OF ITS ANTIDEPRESSANT ACTIVITY AND CLINICAL TOLERABILITY, International clinical psychopharmacology, 12(2), 1997, pp. 99-108
PREVALENCE OF ANXIETY DISORDERS COMORBIDITY IN BIPOLAR DEPRESSION, UNIPOLAR DEPRESSION AND DYSTHYMIA
Authors:
PINI S
CASSANO GB
SIMONINI E
SAVINO M
RUSSO A
MONTGOMERY SA
Citation: S. Pini et al., PREVALENCE OF ANXIETY DISORDERS COMORBIDITY IN BIPOLAR DEPRESSION, UNIPOLAR DEPRESSION AND DYSTHYMIA, Journal of affective disorders, 42(2-3), 1997, pp. 145-153
Authors:
FINEBERG NA
ROBERTS A
MONTGOMERY SA
COWEN PJ
Citation: Na. Fineberg et al., BRAIN 5-HT FUNCTION IN OBSESSIVE-COMPULSIVE DISORDER - PROLACTIN RESPONSES TO D-FENFLURAMINE, British Journal of Psychiatry, 171, 1997, pp. 280-282
Authors:
MONTGOMERY SA
BAKISH D
BULLER R
GJERRIS A
KATSCHNIG H
LECRUBIER Y
LEPINE JP
MAURI M
SATORIUS N
CAMERON A
CASSANO G
COSTAESILVA J
DENBOER JA
FREEMAN C
VONKNORRING L
LOO H
NUTT D
ROSENBERG R
Citation: Sa. Montgomery et al., ECNP POSITION PAPER ON SOCIAL PHOBIA - PROCEEDINGS FROM AN ECNP WORKSHOP IN JERUSALEM, OCTOBER 1994, European neuropsychopharmacology, 6(1), 1996, pp. 77-83
Authors:
PRIEST RG
HAWLEY CJ
KIBEL D
KURIAN T
MONTGOMERY SA
PATEL AG
SMEYATSKY N
STEINERT J
Citation: Rg. Priest et al., RECOVERY FROM DEPRESSIVE-ILLNESS DOES FIT AN EXPONENTIAL MODEL, Journal of clinical psychopharmacology, 16(6), 1996, pp. 420-424
Authors:
MONTGOMERY SA
Citation: Sa. Montgomery, EFFICACY OF NEFAZODONE IN THE TREATMENT OF DEPRESSION, J PSYCHOPH, 10, 1996, pp. 5-10
Authors:
MONTGOMERY SA
Citation: Sa. Montgomery, LONG-TERM MANAGEMENT OF OBSESSIVE-COMPULSIVE DISORDER, International clinical psychopharmacology, 11, 1996, pp. 23-29
Authors:
MONTGOMERY SA
PROST JF
SOLLES A
BRILEY M
Citation: Sa. Montgomery et al., EFFICACY AND TOLERABILITY OF MILNACIPRAN - AN OVERVIEW, International clinical psychopharmacology, 11, 1996, pp. 47-51
Authors:
LEONARD BE
MONTGOMERY SA
Citation: Be. Leonard et Sa. Montgomery, MANAGING DEPRESSION WITH THE WHOLE PATIENT IN MIND - PAPERS PRESENTEDAT AN INTERACTIVE FOCUS CONFERENCE HELD IN PARIS, FRANCE, 2 AND 3 JUNE 1995 - INTRODUCTION, International clinical psychopharmacology, 11, 1996, pp. 3-3